[ad_1]
The UK will start vaccinating people coronavirus next week – the main milestone in the global race to tackle a pandemic that has killed 1.5 million people.
The UK government became the first country in the West on Wednesday officially authorized one of a dozen vaccines being developed since the pandemic began. Referring to “months of rigorous clinical trials and in-depth data analysis,” the UK approved a vaccine from Pfizer and BioNTech, with safe trials and 95% effective in blocking COVID-19.
In a televised interview, UK Health Secretary Matt Hancock praised the speed of his government’s regulators, but said “the vaccine would not be accepted if it were not clinically safe”.
The Pfizer vaccine is one of three that have been given late phase data so far. Test results for the second, Made in modern, It has been shown to be 94% effective. The third person in charge, Oxford University and AstraZeneca, They have released data showing 70% efficiency in general, doubts have arisen about the design of the trial. All vaccines need two shots to work. The UK has not yet approved the Moderna or Oxford University / AstraZeneca vaccine.
In the United States both the Pfizer vaccine and the Moderna vaccine awaiting emergency admission By the Food and Drug Administration. On Dec. 10, an FDA panel will meet to review Pfizer’s vaccine authorization.
Even though the initial vaccinations will start this month, ensuring that enough people are received to keep the pandemic under control will be a major logistical challenge in the coming months. Companies that produce approved vaccines will have to manufacture millions of doses, and governments around the world will have to buy, store and figure out how to reach the people as quickly as possible.
The Pfizer vaccine should be stored cold ultra -70 degrees Celsius, creating additional challenges to distribute easily and equitably.
There is a lively debate about who should receive the first vaccines available. First doses in the UK likely to go to health care workers, because they suffer from the virus, but also because the Pfizer vaccine needs to be stored in very cold temperatures, which makes it easier in hospitals. The next row will be seniors living in nursing homes and people caring for them.
In the US, a The CDC panel voted Tuesday recommending that health workers and people living in nursing homes be vaccinated before everyone else. The jury’s recommendations will help state governors decide who the top priority is.
[ad_2]
Source link
